Bluebird bio Inc (NASDAQ:BLUE): A Fundamentally Weighted Stock for Long-Term Investors
The stock of Bluebird bio Inc (NASDAQ:BLUE) last traded at $1.19, down -5.56% from the previous session. BLUE stock price is now -5.06% away from the 50-day moving average and -54.22% away from the 200-day moving average. The market capitalization of the company currently stands at $229.36M. On December 08, 2023, Morgan Stanley Upgraded its […]
Bluebird bio Inc (BLUE) – Mismatched value: Check Out the Fundamental Analysis
In yesterday’s Wall Street session, Bluebird bio Inc (NASDAQ:BLUE) shares traded at $1.28, down -6.23% from the previous session. BLUE stock price is now 2.18% away from the 50-day moving average and -52.52% away from the 200-day moving average. The market capitalization of the company currently stands at $246.71M. On December 08, 2023, Morgan Stanley […]
The most important numbers to know about Bluebird bio Inc (NASDAQ:BLUE)
Bluebird bio Inc (NASDAQ:BLUE) shares traded 13.75% higher at $1.37 on Wall Street last session. BLUE stock price is now 8.85% away from the 50-day moving average and -49.58% away from the 200-day moving average. The market capitalization of the company currently stands at $263.09M. On December 08, 2023, Morgan Stanley Upgraded its previous ‘Underweight’ […]
Before You Invest In Bluebird bio Inc (NASDAQ:BLUE), Consider This Metric
In yesterday’s Wall Street session, Bluebird bio Inc (NASDAQ:BLUE) shares traded at $1.40, down -2.78% from the previous session. BLUE stock price is now 11.06% away from the 50-day moving average and -49.58% away from the 200-day moving average. The market capitalization of the company currently stands at $269.84M. On December 08, 2023, Morgan Stanley […]
There’s Still Time to Buy Bluebird bio Inc (NASDAQ:BLUE) Stock
In yesterday’s Wall Street session, Bluebird bio Inc (NASDAQ:BLUE) shares traded at $3.07, up 7.34% from the previous session. 15 analysts cover Bluebird bio Inc (NASDAQ:BLUE), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $13.00 and a […]
Does Bluebird bio Inc (NASDAQ:BLUE) presents a BIG investment opportunity?
Stocks of Bluebird bio Inc (NASDAQ:BLUE) traded higher last session on Wall Street, up 11.55% to $4.83. According to the data, Bluebird bio Inc (NASDAQ:BLUE) has 15 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $13.00 and […]
Does Bluebird bio Inc (NASDAQ:BLUE) have deteriorating prospects?
Bluebird bio Inc (NASDAQ:BLUE) shares traded -1.04% lower at $3.82 on Wall Street last session. In accordance with the data, 15 analysts cover Bluebird bio Inc (NASDAQ:BLUE). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $13.00 and a low of $3.00, […]
Stocks of Bluebird bio Inc [BLUE] are gaining investors’ attention: here’s why
Stocks of Bluebird bio Inc (NASDAQ:BLUE) traded higher last session on Wall Street, up 3.55% to $3.79. According to the data, Bluebird bio Inc (NASDAQ:BLUE) has 15 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $13.00 and […]
A Stock With Stellar Fundamentals? Bluebird bio Inc (NASDAQ:BLUE): Is It Right For You?
In yesterday’s Wall Street session, Bluebird bio Inc (NASDAQ:BLUE) shares traded at $3.04, down -7.60% from the previous session. As of this writing, 15 analysts cover Bluebird bio Inc (NASDAQ:BLUE). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $13.00 and a […]
Stocks of Bluebird bio Inc [BLUE] are gaining investors’ attention: here’s why
Stocks of Bluebird bio Inc (NASDAQ:BLUE) traded higher last session on Wall Street, down -7.91% to $3.26. According to the data, Bluebird bio Inc (NASDAQ:BLUE) has 15 analysts covering its stock. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $13.00 and […]
